Back

Obese cardiomyopathy and the role of GLP-1

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Heart failure management in the cardiometabolic era Comorbidities HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

3 More presentations in this session

Presentation thumbnail
Is SiGLT2i the treatment for diabetic cardiomyopathy?
Doctor J. Ferreira (Porto, PT)
Slides Video
Presentation thumbnail
How to manage heart failure in uremic cardiomyopathy
Doctor I. Beldhuis (Groningen, NL)
Slides Video
Presentation thumbnail
Heart failure management in the cardiometabolic era - discussion
Video

Access the full session

Session thumbnail
Heart failure management in the cardiometabolic era
Video

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Session
Weight loss drugs and heart failure
thumbnail
Congress Session
GLP-1RAs in obesity-related HFpEF: a new era in treatment
thumbnail
Congress Session
Management of obesity across the stages of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources